Save 10% off on your first order with coupon code: PANDA10

Health & Wellness Blog

10Feb, 2026

Rybelsus Cost 2026: $998 List vs $10 Insured + Walmart Pricing Guide

February 10, 2026|

Rybelsus lists at $997.58 monthly for all doses (3mg, 7mg, and 14mg), but with the Novo Nordisk savings card and commercial insurance, the out-of-pocket cost can drop to as low as $10. As the first FDA-approved oral GLP-1 receptor agonist, Rybelsus offers the convenience of a daily pill versus weekly injections like Ozempic or Wegovy, [...]

9Feb, 2026

Victoza vs Saxenda: Same Drug, Different Doses – Diabetes vs Weight Loss Pens

February 9, 2026|

Victoza and Saxenda are both brand-name drugs manufactured by Novo Nordisk that contain the same active ingredient: liraglutide. Despite sharing an identical GLP-1 molecule, these two medications have different FDA approvals and maximum dosing. Victoza (liraglutide 0.6-1.8mg daily) is approved for managing blood sugar levels in adults with type 2 diabetes, while Saxenda (liraglutide 3.0mg [...]

9Feb, 2026

Saxenda Dosage Guide: 0.6mg Start to 3mg Max (5-Week Titration Schedule)

February 9, 2026|

Saxenda dosing starts at 0.6 mg once daily and is gradually increased by 0.6 mg every week until reaching the maintenance dose of 3.0 mg daily-this FDA-approved titration schedule takes approximately 5 weeks to complete. The active ingredient in Saxenda is liraglutide, a GLP-1 receptor agonist manufactured by Novo Nordisk for chronic weight management in [...]

9Feb, 2026

Trulicity vs Zepbound: 4-7% vs 21% Loss – Dual GIP/GLP-1 vs GLP-1

February 9, 2026|

Zepbound delivers dramatically superior weight loss results: participants in clinical trials lost an average of 21% body weight (approximately 48 lbs at the highest dose) compared to Trulicity's modest 4-7% weight loss (7-10 lbs). This substantial difference stems from their fundamentally different mechanisms-Zepbound is a dual GIP and GLP-1 receptor agonist, while Trulicity operates solely [...]

9Feb, 2026

Contrave vs Zepbound 2026: 22.5% vs 8.1% Weight Loss – Pill vs Dual Hormone Injection

February 9, 2026|

Zepbound (tirzepatide) produces approximately 22.5% average total body weight loss at the maximum 15 mg dose over 72 weeks, according to the SURMOUNT-1 clinical trial published in the New England Journal of Medicine. Contrave (naltrexone/bupropion) shows an average of 8.1% total body weight loss at the maximum daily dose over 56 weeks, as documented in [...]

7Feb, 2026

Does Zepbound Cause Depression? No Direct Link + Mood Monitoring Guide

February 7, 2026|

Zepbound (tirzepatide) does not directly cause depression according to clinical evidence. The FDA's comprehensive review of over 107,000 patients found no increased risk of suicidal ideation or behavior (SI/B) associated with GLP-1 receptor agonist medications, including tirzepatide. In January 2026, the FDA requested manufacturers remove the suicide and depression warnings from Zepbound's label based on [...]

20Feb, 2026

Trulicity Coupon 2026: $25 Savings Card, Copay, Discounts Guide

February 20, 2026|

As of early 2026, the average retail price of Trulicity without insurance is approximately $1,395.75 for four Trulicity pens a standard 30-day supply. The good news: several savings programs exist to help eligible patients dramatically reduce what they pay out [...]

17Feb, 2026

Zepbound Insurance Coverage: Complete Guide to Prior Authorization & Approval

February 17, 2026|

Zepbound insurance coverage stands at approximately 45% for commercial plans requiring BMI ≥30 or ≥27 with comorbidities, while Medicare excludes weight-loss indications entirely. Employer-sponsored plans show 55% approval rates after prior authorization. Roughly 97 million Americans are in plans that [...]

13Feb, 2026

Mounjaro Dosage: Complete 2.5mg→15mg Titration Chart + Missed Dose Protocol

February 13, 2026|

Mounjaro (tirzepatide) is an FDA-approved once-weekly injectable medicine manufactured by Eli Lilly for adults and children aged 10 years and older with type 2 diabetes. The active ingredient tirzepatide is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) [...]

6Feb, 2026

Does Mounjaro Make You Tired? 8-12% Fatigue Rate + Evidence-Based Recovery

February 6, 2026|

Mounjaro (tirzepatide) is an FDA-approved medication to treat type 2 diabetes and support weight loss by mimicking two naturally occurring hormones: glucose-dependent insulinotropic polypeptide (GIP) and GLP-1. These hormones work by enhancing insulin secretion, reducing appetite, slowing gastric emptying, and [...]

5Feb, 2026

Trulicity vs Wegovy: Wegovy 15% Weight Loss vs Trulicity 7 lbs – Diabetes vs Obesity Drugs

February 5, 2026|

Wegovy delivers approximately 15% body weight loss in clinical trials-dramatically outperforming Trulicity’s average weight reduction of about 7–10 lbs (3–5% of body weight). Both are GLP-1 receptor agonists administered as once-weekly injections, yet Wegovy produces roughly 2.5 times greater weight [...]

1Sep, 2025

Ozempic vs Insulin

September 1, 2025|

Effective blood glucose management is a critical need for many. Ozempic and insulin are two commonly used diabetes medications. While both address diabetes, they function differently. Ozempic is a prescription medication for adults with type 2 diabetes. Interestingly, it also [...]

4Aug, 2025

Is Compounded Mounjaro Safe? Understanding Tirzepatide Compounding for Informed Choices

August 4, 2025|

Tirzepatide is a prescription drug that has been gaining popularity. Millions are exploring it for weight management and diabetes. But sometimes, the exact medication isn't readily available. This leads to "compounding."  What are Compounded Drugs? Compounded versions of medications are [...]

3Jun, 2025

Does Ozempic Cause Hair Loss?

June 3, 2025|

You've scrolled through social media, seen the news, and maybe even heard friends talking about Ozempic and its remarkable weight loss results. It's become a household name, but with its growing popularity comes a wave of questions, especially regarding potential [...]

Go to Top
X